Conor Medsystems Harvard Case Solution & Analysis

Conor Medsystems was developed drug-eluting stent, which could capture a significant share of the $ 5 billion global market. Chief Executive Officer Frank Litvack, exploring alternative sources of funding for testing the device. "Hide
by Linda A. Cyr, Bijan Salehizadeh, Robert F. Higgins, Donald N. Sull Source: Harvard Business School 29 pages. Publication Date: April 28, 2004. Prod. #: 804180-PDF-ENG

Conor Medsystems Case Solution Other Similar Case Solutions like

Conor Medsystems

Share This